Athens, GA, United States of America

Bruce S Seal


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bruce S Seal: Innovator in Antimicrobial Solutions

Introduction

Bruce S Seal is a notable inventor based in Athens, GA, who has made significant contributions to the field of microbiology and antimicrobial research. With a total of three patents to his name, he has focused on developing innovative solutions to combat viral infections in poultry.

Latest Patents

One of his latest patents involves the use of bacteriophage lytic enzymes as alternative antimicrobials. This invention relates to isolated bacteriophage lytic enzymes derived from bacteriophages CP26F and CP39O. These enzymes are utilized in controlling Avian astrovirus, a unique turkey astrovirus that has been isolated and sequenced. Additionally, primers and probes have been developed using the isolated nucleic acid sequence of the astrovirus, and a reverse transcriptase PCR has been created to detect the presence of avian astrovirus in commercial flocks. Furthermore, purified antigenic polypeptides have been synthesized from each of the open reading frames 1a, 1b, and 2 of the novel virus.

Career Highlights

Throughout his career, Bruce has worked with various organizations, including the United States of America, as represented by the Secretary of Agriculture. His work has been instrumental in advancing the understanding and management of viral infections in poultry.

Collaborations

Bruce has collaborated with esteemed colleagues such as Stacey L Schultz-Cherry and Laura Kelley, contributing to the collective knowledge and research in the field of antimicrobial solutions.

Conclusion

In summary, Bruce S Seal is a dedicated inventor whose work in developing bacteriophage lytic enzymes has the potential to revolutionize the way we approach viral infections in poultry. His innovative research continues to pave the way for new antimicrobial solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…